chartexchange

GRI
GRI Bio, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:54:11 PM EST
1.28USD+0.787%(+0.01)27,745
Pre-marketNov 18, 2026 8:09:30 AM EST
1.3187USD+3.835%(+0.0487)
After-hoursNov 18, 2026 4:00:30 PM EST
1.27USD-0.781%(-0.01)
1.0700Bid1.6000Ask0.5300Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Jolla, CA, USA
Previous Close
$1.27
Beta
0.63
52-Week High
$64.12 2025-11-24
52-Week Low
$1.25 2026-11-18
SMA 50
$1.71
SMA 200
$2.02
Avg. Vol 10D
56,053
Avg. Vol 30D
46,709
Avg. Vol 90D
247,279
Relative Vol
0.51
2.19M
8.9300%
5,165
Dec 20, 2018 · $0.409
Jan 26, 2026 · 1-for-28 (reverse)
GRI Profile

gri is a development stage biotech company fundamentally changing the way inflammatory disease is treated. gri's natural killer t (nkt) cell-based therapies are being developed for liver disease and acute liver failure. nkt cells share properties of both nk and t cells and are a functional link between the innate and adaptive immune responses. type 1 nkt cells play a critical role in initiating and propagating the inflammatory response and the hepatic injury that is observed in liver disease. gri's lead program, gri-0621, is an inhibitor of type i nkt cells and is being developed as a novel oral therapeutic for acute liver failure.

GRI Performance
PeriodPriceDateChangeBeta
1W1.822026-11-12-35.71%6.688
1M1.452026-10-19-19.31%-0.290
3M1.732026-08-19-32.37%0.727
6M2.232026-05-19-47.53%0.348
1Y47.322025-11-19-97.53%0.626
2Y326.202024-11-19-99.64%—
5Y371,867.862023-04-24-100.00%0.941
GRI Stock Summary

GRI Bio, Inc. Common Stock (NASDAQ:GRI) stock price today is $1.17, and today's volume is 23,712. GRI is down 7.874% today. The 30 day average volume is 46,709. GRI market cap is $2.56M with 2.19M shares outstanding.